NCT00000231已完成2 期
Buprenorphine Detoxification With Two Types of Treatment. BBD IV
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 2
- 主要终点
- Retention
研究概览
简要总结
The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with pro-social activities. In addition, we will examine whether blind naltrexone dosing is effective in indicating naltrexone consumption.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Retention
Overall treatment outcome
Naltrexone consumption
Drug use
Weeks abstinent
Weeks continuous abstinence
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12Opioid-Related DisordersNCT00000230University of Vermont
已完成
2 期
Buprenorphine Detox With Two Types of Treatment. BBD II - 11Opioid-Related DisordersNCT00000229University of Vermont
已完成
2 期
Buprenorphine Detox With Two Types of Treatment. BBD I - 10Opioid-Related DisordersNCT00000228National Institute on Drug Abuse (NIDA)
已完成
2 期
Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22Cocaine-Related DisordersOpioid-Related DisordersNCT00000240University of Vermont
已完成
4 期
Buprenorphine Maintenance vs. Detoxification in Prescription Opioid DependenceOpiate DependenceNCT00555425Yale University113